Bioceltix S.A. (WSE: BCX)
Poland flag Poland · Delayed Price · Currency is PLN
82.40
-0.50 (-0.60%)
Jan 20, 2025, 12:49 PM CET

Bioceltix Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21
Market Capitalization
412372133172
Market Cap Growth
31.29%179.48%-22.49%-
Enterprise Value
375357130-
Last Close Price
83.7090.0038.8052.20
PB Ratio
9.9535.5125.8228.60
P/TBV Ratio
8.0335.5125.8228.60
Debt / Equity Ratio
0.020.020.060.09
Quick Ratio
15.505.231.943.41
Current Ratio
15.515.242.683.42
Return on Equity (ROE)
-56.22%-175.28%-160.02%-
Return on Assets (ROA)
-32.11%-85.92%-70.62%-
Return on Capital (ROIC)
-34.66%-108.90%-93.47%-
Earnings Yield
-4.57%-3.68%-6.71%-2.56%
FCF Yield
-4.49%-4.09%-6.19%-2.35%
Buyback Yield / Dilution
-7.65%-17.48%-5.54%-
Total Shareholder Return
-7.65%-17.48%-5.54%-
Source: S&P Capital IQ. Standard template. Financial Sources.